Article

New approach possible to management of perforating ocular injuries

A new preventive approach to perforating ocular injuries seems to prevent the almost inevitable development of proliferative vitreoretinopathy (PVR) that follows this type of injury, according to Ferenc Kuhn, MD, PhD, of the University of Alabama, Birmingham.

New Orleans-A new preventive approach to perforating ocular injuries seems to prevent the almost inevitable development of proliferative vitreoretinopathy (PVR) that follows this type of injury, according to Ferenc Kuhn, MD, PhD, of the University of Alabama, Birmingham.

Standard treatment of perforating injuries includes closing the entrance wound during an initial surgery, a pars plana vitrectomy 6 to 10 days later to clear the hemorrhage and apply laser retinopexy around the exit wound. After the development of retinal detachment and PVR, another and possibly additional surgeries are needed to remove proliferative tissue.

Dr. Kuhn advised using a new approach during retina subspecialty day at the American Academy of Ophthalmology annual meeting.

"Prevent the PVR and retinal folds from developing," he said. In his treatment approach, he advised closing the entry and exit wounds and performing anterior segment manipulations. Postoperative care includes heavy topical occasionally systemic steroid therapy to minimize the inflammation. In a second surgery performed 3 days later, vitrectomy is then performed. Diathermy is applied around the exit wound involving the retina and the choroids.

Dr. Kuhn reported that in the five patients who have undergone this procedure, no PVR or retinal folds have developed.

"The traditional approach increases complications. The new approach should be offered as a better option to patients," he said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
© 2025 MJH Life Sciences

All rights reserved.